Tenosynovial Giant Cell Tumor
📧 Sign up to get email alerts when something new happens for Tenosynovial Giant Cell Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ... [Phase 1]
Phase I trial of pexidartinib (TURALIO) in children and young adults with refractory leukemias and solid tumors including NF1-associated ple…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER) [Phase 2]
Phase 2 study of Pimicotinib in Japanese participants with Tenosynovial Giant Cell Tumor is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor [Phase 1]
Phase 1 study to assess the safety, tolerability, and pharmacokinetics of ABSK-021 in patients with advanced solid tumors. The study include…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) [Phase 3]
A Phase 3 clinical trial evaluating emactuzumab for Tenosynovial giant cell tumor is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Tenosynovial Giant Cell Tumor Surgery [Phase 4]
Phase 4 clinical trial evaluating the accuracy of Indocyanine Green fluorescence imaging during surgery for Tenosynovial Giant Cell Tumor; c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor [Phase 1, Phase 2]
Clinical trial update on Vimseltinib (DCC-3014) for advanced tumors and tenosynovial giant cell tumor (pigmented villonodular synovitis), cu…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
A long-term clinical trial is evaluating potential liver toxicity associated with TURALIO (pexidartinib) treatment in patients with Tenosyno…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER) [Phase 3]
Phase 3 clinical trial update for Pimicotinib (ABSK021) in Tenosynovial Giant Cell Tumor, including Pigmented Villonodular Synovitis and Gia…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: A Comparative Study of the Efficacy of Multimodal Interventions for Tenosynovitis [NA]
A clinical trial update for a study evaluating multimodal interventions for tenosynovial giant cell tumor (TGCT) is not yet recruiting.